...
首页> 外文期刊>Circulation research: a journal of the American Heart Association >TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1 alpha (Chemokine Stromal Cell-Derived Factor-alpha) Axis Suppresses Diabetic Retinopathy
【24h】

TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1 alpha (Chemokine Stromal Cell-Derived Factor-alpha) Axis Suppresses Diabetic Retinopathy

机译:TPL2(治疗靶向肿瘤进展基因座-2)/ ATF4(激活转录因子-4)/SDF1α(趋化因子基质细胞衍生因子-α)轴抑制糖尿病视网膜病变

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Rationale: Diabetic retinopathy is characterized by vasopermeability, vascular leakage, inflammation, blood-retinal barrier breakdown, capillary degeneration, and neovascularization. However, the mechanisms underlying the association between diabetes mellitus and progression retinopathy remain unclear.
机译:理由:糖尿病视网膜病变的特征在于血管复属性,血管泄漏,炎症,血尿病势垒分解,毛细血管变性和新血管形成。 然而,糖尿病和进展视网膜病变之间的相关机制仍然不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号